Key result
NSAP1 augments Hepatitis C virus mRNA translation through a specific interaction with an adenosine-rich protein-coding region downstream of the initiation codon.
NSAP1 enhances HCV mRNA translation through interaction with a protein-coding sequence, revealing a novel mechanism of translational enhancement.
Hypothesis-generating for host-directed HCV antivirals; leaves open clinical translation pending validation.
Translational initiation of hepatitis C virus (HCV) mRNA occurs by internal entry of ribosomes into an internal ribosomal entry site (IRES) at the 5' nontranslated region. A region encoding the N-terminal part of the HCV polyprotein has been shown to augment the translation of HCV mRNA. Here we show that a cellular protein, NS1-associated protein 1 (NSAP1), augments HCV mRNA translation through a specific interaction with an adenosine-rich protein-coding region within the HCV mRNA. The overexpression of NSAP1 specifically enhanced HCV IRES-dependent translation, and knockdown of NSAP1 by use of a small interfering RNA specifically inhibited the translation of HCV mRNA. An HCV replicon RNA capable of mimicking the HCV proliferation process in host cells was further used to confirm that NSAP1 enhances the translation of HCV mRNA. These results suggest the existence of a novel mechanism of translational enhancement that acts through the interaction of an RNA-binding protein with a protein coding sequence.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2004) studied Hepatitis C Virus (HCV) translation. NSAP1 overexpression and siRNA knockdown vs. Control vectors was evaluated on HCV IRES-dependent translation activity. NSAP1 augments Hepatitis C virus mRNA translation through a specific interaction with an adenosine-rich protein-coding region downstream of the initiation codon.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: